India's Richest People 2026 edition · 1 director · Source: Hurun India
- #169 M Satyanarayana Reddy & family ₹21,600 Cr
Revenue · FY 2024
₹1,716.51 Cr
▲ 40% YoY
Net profit · FY 2024
₹238.71 Cr
Net margin 13.9%
EBITDA · FY 2024
₹374.79 Cr
EBITDA margin 21.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.5 Cr
Issued & subscribed
Open charges
₹1,950.75 Cr
Satisfied ₹34.59 Cr
Company age
22 yrs
Est. 2004
Employees · EPFO
1,156
Provident fund records
About MSN Pharmachem Private Limited
Data last updated:
MSN Pharmachem Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 November 2004 and has been in existence for over 22 years.
Its director M Satyanarayana Reddy and family are #169 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044631. Its GSTIN is 36AAECM0740L1ZH (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.5 Cr. It is led by directors Satyanarayana Reddy Manne (Managing Director) and Laxmi Prasuna Manne.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1,716.51 Cr, a growth of 40% compared to the previous year. For the same year it recorded a net profit of ₹238.71 Cr (net margin 13.9%) and EBITDA of ₹374.79 Cr (EBITDA margin 21.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 6% over five years.
The company has about 1,156 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1,950.75 Cr and satisfied charges of ₹34.59 Cr on record. Court records list 17 cases involving the company, including 7 filed by the company and 10 filed against it; 3 cases are pending. The company has 5 deals on record (5 secondary share transfers); the latest was in March 2023. Its 8 peer companies in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 3 smaller; the largest is Bharat Serums and Vaccines Limited with revenue of ₹1,831.99 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website msnlabs.com.
Company details
CIN U24239TG2004PTC044631
Registration Number 044631
Incorporation Date 17 November 2004
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
CIN history
MSN Pharmachem has one previous CIN (Corporate Identification Number): U24239AP2004PTC044631. The current CIN is U24239TG2004PTC044631, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044631 | Current |
| U24239AP2004PTC044631 | Previous |
Recognitions & Rankings of MSN Pharmachem
Contact details
MSN Pharmachem Private Limited's registered office is in Hyderabad, Telangana. Its website is msnlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMsn House Plot No. C 24 Sanath Nagar Industrial Estate Sanath N, Agar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development, API Manufacturers
To see the full contact details of MSN Pharmachem Private Limited, buy the company report.
Comprehensive company report
MSN Pharmachem Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of MSN Pharmachem is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of MSN Pharmachem Private Limited, buy the company report.
Financials of MSN Pharmachem Private Limited
FY 2024 filings availableMSN Pharmachem Private Limited reported revenue of ₹1,716.51 Cr (up 40% YoY) for FY 2024.
Revenue · FY 2024
₹1,716.51 Cr ▲ 40%
Net profit · FY 2024
₹238.71 Cr margin 13.9%
EBITDA · FY 2024
₹374.79 Cr margin 21.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 40%
3 years · compounded
▲ 2%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 158%
3 years · compounded
▲ 2%
5 years · compounded
▲ 8%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 40% growth in the latest year. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹374.79 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹238.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.8% | ||||
| Net Profit Margin | 13.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of MSN Pharmachem Private Limited, buy the company report.
Board of directors of MSN Pharmachem Private Limited
MSN Pharmachem has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satyanarayana Reddy Manne | Managing Director | 17 Nov 2004 | 21 Years 11 Months | Current |
| Laxmi Prasuna Manne Also directs: MSN Urban Ventures LLP, MSN Facades LLP, Varenya Horticulture Private Limited and 5 more | Director | 17 Nov 2004 | 21 Years 11 Months | Current |
Peer comparison
MSN Pharmachem Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bharat Serums and Vaccines Limited | ₹1,831.99 Cr (FY 2025) | 6.0% | Thane, Maharashtra, India | |||
| Morepen Laboratories Limited | ₹1,829.94 Cr (FY 2025) | 7.0% | Himachal Pradesh, India | |||
| Avet Lifesciences Private Limited | ₹1,801.29 Cr (FY 2025) | 20.0% | Pune, Maharashtra, India | |||
| Astrazeneca Pharma India Limited | ₹1,756.92 Cr (FY 2025) | 32.0% | Bangalore, Karnataka, India | |||
| Leeford Healthcare Limited | ₹1,730.47 Cr (FY 2025) | 5.0% | Ludhiana, Punjab, India | |||
| MSN Pharmachem Private Limitedthis company | ₹1,716.51 Cr (FY 2024) | ₹238.71 Cr | 13.9% | 40.0% | 1,156 | Hyderabad, Telangana, India |
| Bharat Biotech International Limited | ₹1,699.59 Cr (FY 2025) | 4.0% | Hyderabad, Telangana, India | |||
| Indoco Remedies Limited | ₹1,670.37 Cr (FY 2025) | -9.0% | Mumbai, Maharashtra, India | |||
| Dishman Pharmaceuticals and Chemicals Limited | ₹1,622.59 Cr (FY 2016) | -3.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of MSN Pharmachem Private Limited, buy the company report.
Auditor
MSN Pharmachem Private Limited is audited by B.R.M. REDDY AND CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B.R.M. REDDY AND CO. | FY 2023 | 0003247S |
Shareholding
The shareholding of MSN Pharmachem Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of MSN Pharmachem Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1,950.75 Cr
Satisfied charges
₹34.59 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Oct 2025 | 101174662 | Others | ₹1,358 Cr | Open | |
| 05 Dec 2024 | 101024160 | Axis Bank Limited | ₹4.5 Cr | Open | |
| 16 Mar 2024 | 100893250 | Axis Bank Limited | ₹5.36 Cr | Open | |
| 06 Mar 2024 | 100890053 | Citi Bank N.A. | ₹100 Cr | Open | |
| 31 Jul 2023 | 100756132 | Axis Bank Limited | ₹31.53 Lakh | Open |
To see the full charge records of MSN Pharmachem Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
MSN Pharmachem Private Limited has 5 deals on record (5 secondary share transfers); the latest was in March 2023.
Total deals
5
Secondary share transfers
5
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
| Dec 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
MSN Pharmachem Private Limited has 17 court cases on record: 7 filed by MSN Pharmachem, 10 filed against it. 3 cases are pending and 14 are disposed.
Total cases
17
Filed by the company
7
Filed against the company
10
Pending
3
Disposed
14
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 6 | 0 |
| High courts | 6 | 4 | 3 |
Cases on record (5 of 17)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Writ petition | Filed by the company against Pegasus Assets Reconstruction Pvt. Ltd. and 7 others | Pending |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms. Ameya Laboratories Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against Anus Laboratories Ltd., and Another | Disposed |
| High Court for State of Telangana | Court case (ITTA) | Filed against the company by The Assistant Commissioner of Income Tax | Pending |
| High Court for State of Telangana | Court case (ITTA) | Filed against the company by The Assistant Commissioner of Income Tax, | Pending |
To see the full case history of MSN Pharmachem Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for MSN Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
MSN Pharmachem Private Limited has a workforce of 1,156 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
1,156
Active EPFO establishments
1
Employee growth
21.3%
GST
MSN Pharmachem has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECM0740L1ZH | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of MSN Pharmachem Private Limited, buy the company report.
Recent activity
MSN Pharmachem Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Laxmi Prasuna Manne was appointed as Director on 17 Nov 2004.
Charges
A charge with Others amounted to Rs. 1,358.00 Cr with Charge ID 101174662 was registered on 31 Oct 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.50 Cr with Charge ID 101024160 was registered on 05 Dec 2024.
AGM
Msn Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Msn Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 30 Oct 2018 via Charge ID 100215054 with Axis Bank Limited was fully satisfied on 20 Mar 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 5.36 Cr with Charge ID 100893250 was registered on 16 Mar 2024.
Charges
A charge with Citi Bank N.A. amounted to Rs. 100.00 Cr with Charge ID 100890053 was registered on 06 Mar 2024.
Charges
A charge with Citi Bank N.A. of Rs. 203.00 Cr registered on 29 Mar 2010 with Charge ID 10211274 was modified on 06 Mar 2024.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.32 Cr with Charge ID 100756132 was registered on 31 Jul 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.37 Cr with Charge ID 100749275 was registered on 28 Jun 2023.
Charges
A charge registered on 09 Dec 2019 via Charge ID 100312530 with Axis Bank Limited was fully satisfied on 15 Mar 2023.
Charges
A charge registered on 22 Mar 2021 via Charge ID 100437195 with Hdfc Bank Limited was fully satisfied on 01 Mar 2023.
21 earlier events are in the company report.
News
Frequently asked questions
MSN Pharmachem is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 November 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044631.
MSN Pharmachem has 2 current directors:
- Satyanarayana Reddy Manne - Managing Director
- Laxmi Prasuna Manne - Director
The latest financial statements of MSN Pharmachem on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of MSN Pharmachem is 36AAECM0740L1ZH, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of MSN Pharmachem is U24239TG2004PTC044631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
MSN Pharmachem has 17 court cases on record: 7 filed by the company and 10 filed against it. 3 are pending. Most are in the district courts.
MSN Pharmachem was incorporated on 17 November 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
MSN Pharmachem has 5 deals on record (5 secondary share transfers); the latest was in March 2023.
The peers of MSN Pharmachem by revenue are Bharat Serums and Vaccines Limited, Morepen Laboratories Limited, Avet Lifesciences Private Limited, Astrazeneca Pharma India Limited, Leeford Healthcare Limited and 3 more, all in the Pharma industry (API Manufacturers, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Laxmi Prasuna Manne was appointed as Director on 17 Nov 2004. Satyanarayana Reddy Manne was appointed as Managing Director on 17 Nov 2004.
MSN Pharmachem can be reached through the website msnlabs.com. Its registered office is in Hyderabad, Telangana, India.